American Tungsten & Antimony Ltd
(ASX: $AT4 | OTCQB: $ATALF)
AT4 has recently secured the fully permitted Dutch Mountain Processing Facility in Utah — the only operationally proven tungsten mill in the district — along with the historic Fraction Lode mine.
This brownfields infrastructure dramatically compresses development timelines.
Refurbishment plans are advancing to bring processing capacity online efficiently. Combined with high-grade tungsten deposits in the portfolio, this creates a ready-made production hub capable of delivering domestic tungsten supply in the near term.
AT4 is building the infrastructure foundation for secure, accelerated U.S. tungsten output when Western markets need it most.
@ATAA_AT4
#Tungsten #CriticalMinerals #DomesticProduction #Ad
$COSM Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value
🔗 https://t.co/qBGzOfnHQG
#NEWS#breakingnews NASDAQ
$LBRG Ladybug Resource Group Inc. Unveils Proprietary AI-Driven Digital Infrastructure, Reopening Efficiency in the Global EV Supply Chain
🔗 https://t.co/okeRu1P8r9
TULSA, OK - June 4, 2026 (NEWMEDIAWIRE) - Ladybug Resource Group, Inc. ("Ladybug" or the "Company") (OTC ID: LBRG) today highlighted the technological foundation underlying its newly acquired manufacturing assets: a proprietary, AI-enhanced digital operating ecosystem designed to address longstanding inefficiencies in the non-standard industrial parts sector.
While traditional precision manufacturing operations often face challenges related to scalability, workflow coordination, and labor oversight, the Company's Guangzhou JingDiao assets operate through a self-developed Manufacturing Execution System ("MES"). This integrated digital platform serves as a centralized, real-time production interface that coordinates each stage of the manufacturing process - from initial 3D design and 5-axis CNC machining through final inspection and delivery.
Advancing Precision Through Data-Driven Manufacturing
The Company's proprietary performance management system reflects a transition from conventional factory oversight to data-driven operational control. By utilizing localized algorithms to monitor worker productivity, machine utilization, and workflow efficiency in real time, JingDiao has been able to bring greater consistency, traceability, and process discipline to the highly customized non-standard manufacturing environment.
Key features of the digital infrastructure include:
Real-Time Visualization: A comprehensive digital dashboard enables management to monitor project status, production milestones, and resource allocation across the manufacturing cycle through a centralized interface.
AI-Enhanced Machine Vision: In addition to automotive applications, the Company has commercialized high-precision AI inspection units for the packaging industry. These systems, which have generated gross margins of approximately 57%, utilize advanced optical recognition technology to detect micro-defects at speeds beyond manual inspection capabilities.
Accelerated Lead Times: By digitizing critical elements of its supply chain and production workflow, the Company has shortened production cycles for complex EV fixtures and related equipment, supporting the rapid turnaround requirements of high-growth manufacturing customers.
Strategic Moat and Scalable Platform
"We are not merely operating a factory; we are operating a digitally integrated industrial platform," said Mr. Shicai Li, CEO of the JingDiao assets. "The digital infrastructure we have built allows us to manage manufacturing complexity at scale. This software-enabled operating model has supported strong operational efficiency while serving demanding customers in the EV and industrial sectors. We believe this technology provides a scalable blueprint for the future of smart manufacturing."
Industrial AI as a Growth Opportunity
The Company's expansion into Industrial AI represents an additional potential growth driver. The core components of its AI-based detection systems are achieving high precision and addressing an important need in the automated quality-control market. This cross-industry application highlights the portability of the Company's technology and intellectual property beyond automotive manufacturing alone.
$COSM Ten Reasons Why You Need to Look at Cosmos Health Inc. Now!
https://t.co/hyPAfkGGV4
NASDAQ: COSM $HUBC $BJDX GXAI DXST SDA LASE ABTS STAK LLY LOBO NVDA QUCY
$COSM Ten Reasons Why You Need to Look at Cosmos Health Inc.
https://t.co/hyPAfkGGV4
NASDAQ plays: COSM $HUBC $BJDX GXAI DXST SDA LASE ABTS STAK CING LOBO NVDA QUCY
$COSM today highlighted its balance sheet transformation, reaffirmed its growth trajectory, and noted no known business reason for the recent decline in its share price.
🔥 Breaking News: Cosmos Health (NASDAQ: $COSM) Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline
⚡ Significant Deleveraging: Total liabilities decreased by $4.5 million, or 9.6%, quarter-over-quarter, while stockholders' equity increased 7.6%
💵 Landmark Financing: R&D division in discussions with the European Investment Bank for financing of up to €25 million
📈 Capital Structure Simplification: 4,874,126 Series B Warrants expired unexercised, eliminating ~38% of total warrant overhang with zero shareholder dilution
💵 Real Estate Value: Wholly-owned facilities independently valued at approximately $15 million — exceeding current market capitalization
💵 Balance Sheet Transformation: Guidance projects stockholders' equity of $92.3 million by 2029, driven by a growing cash position of $62.9 million from internally generated cash flow
Greg Siokas, CEO of Cosmos Health, stated: “The fundamentals speak for themselves. Total liabilities are down $4.5 million in a single quarter, while stockholders' equity is up 7.6%. The market value of our real estate assets alone — wholly owned and independently valued at approximately $15 million — exceeds our current market capitalisation. Our R&D division is in discussions with the European Investment Bank for financing of up to €25 million toward a €50 million R&D program. We have eliminated 38% of our warrant overhang with zero dilution to shareholders. And our guidance projects revenue more than tripling to $200.6 million by 2029, with stockholders' equity growing fourfold to $92.3 million and a cash position of $62.9 million. We are aware that our share price has not reflected this progress, and we do not believe that disconnect is justified by our fundamentals. The growth is happening. We look forward to demonstrating that in the quarters ahead.”
💵 Capital Structure Simplified — Zero Dilution
4,874,126 Series B Warrants have expired unexercised, eliminating approximately 38% of total outstanding warrants with no shareholder dilution. This represents a meaningful simplification of the Company's capital structure that directly benefits existing shareholders.
News & Disclaimer
https://t.co/PPO2Bkq2VY
$COSM 🗞️ Breaking News-->> Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory
🔗 https://t.co/bmBg8MsoV1
#news#breakingnews